Rentokil Initial plc (FRA:RTO1)
Germany · Delayed Price · Currency is EUR | Market Cap | 10.22B -2.9% |
| Revenue (ttm) | 6.24B +6.2% |
| Net Income | 418.39M +44.0% |
| EPS | 0.16 +43.7% |
| Shares Out | n/a |
| PE Ratio | 24.43 |
| Forward PE | 15.71 |
| Dividend | 0.11 (2.67%) |
| Ex-Dividend Date | Aug 13, 2026 |
| Volume | n/a |
| Open | 4.080 |
| Previous Close | 4.025 |
| Day's Range | 4.080 - 4.080 |
| 52-Week Range | 3.968 - 5.868 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About Rentokil Initial
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey, and Pacific. The company offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management. It provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene u... [Read more]
Financial Performance
In 2025, Rentokil Initial's revenue was $6.91 billion, an increase of 4.40% compared to the previous year's $6.62 billion. Earnings were $470.00 million, an increase of 19.90%.
Financial numbers in USD Financial StatementsNews
Rentokil Initial price target lowered to 405 GBp from 465 GBp at Deutsche Bank
Deutsche Bank analyst James Beard lowered the firm’s price target on Rentokil Initial (RTO) to 405 GBp from 465 GBp and keeps a Hold rating on the shares. Published first…
Rentokil Initial downgraded to Neutral from Outperform at BNP Paribas
BNP Paribas downgraded Rentokil Initial (RTO) to Neutral from Outperform with a $26.70 price target
Rentokil Initial falls -18.3%
Rentokil Initial (RTO) is down -18.3%, or -$5.38 to $24.05.
Rentokil Initial falls -17.9%
Rentokil Initial (RTO) is down -17.9%, or -$5.28 to $24.15.
Rentokil Initial Q2 Earnings Call Highlights
Rentokil Initial NYSE: RTO reported higher first-half revenue, profit and free cash flow, while outlining a new operational plan centered on customer service, sales execution and business simplificati...
Rentokil Initial Earnings Call Transcript: Q2 2026
H1 saw revenue and profit growth, strong cash conversion, and improved customer retention. North America and international segments performed well, though commercial lagged behind residential. Cost efficiencies, portfolio simplification, and investments in frontline and digital capabilities are expected to drive future growth.
Rentokil Initial Quarterly report: Q2 2026
Rentokil Initial has published its Q2 2026 quarterly earnings report on July 30, 2026.
Rentokil Initial Slides: Q2 2026
Rentokil Initial has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Rentokil Initial reinstated with a Buy at BofA
BofA reinstated coverage of Rentokil Initial (RTO) with a Buy rating and 515 GBp price target Citing attractive market characteristics, substantial management change and material self-help, the firm s...
Rentokil Initial upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Suhasini Varanasi upgraded Rentokil (RTO) Initial to Buy from Neutral with a price target of 590 GBp, up from 515 GBp. The organic growth inflection in North…
The Round of 32 Pest Scouting Report: Which Host Cities Face a "Double Threat"?
MEMPHIS, Tenn.--(BUSINESS WIRE)--With one of the world's biggest sporting events already underway and millions of international visitors on the ground across U.S. cities, new data from Terminix®, a Re...
Vouched Achieves Kantara Initiative Approval for NIST 800-63A Identity Assurance Level 2 (IAL2) Ready to Operate
SEATTLE--(BUSINESS WIRE)--Vouched, the leading provider of AI-powered identity verification, today announced it has received Ready to Operate (RTO) approval from the Kantara Initiative for NIST Specia...
Rentokil Terminix Launches Multi-Brand Digital Advancements to Enhance Customer Experience
DALLAS, June 23, 2026 (GLOBE NEWSWIRE) -- Experience a smarter way to manage pests. Rentokil Terminix is upgrading its digital lineup to simplify how customers manage their pest control needs, with ea...
Terminix Debuts New Podcast to Help Businesses Mitigate Operational Risk
The pest collective: “From root cause to real solutions” launches this Spring The pest collective: “From root cause to real solutions” launches this Spring
Rentokil Initial Earnings Call Transcript: Q1 2026
Q1 revenue grew 3.4% organically to $1.7B, led by North America and solid international gains. Business Services saw exceptional growth, though not expected to persist, while pricing remains the main driver amid stable retention and minimal impact from fuel or supply chain risks.
Rentokil Initial Earnings release: Q1 2026
Rentokil Initial released its Q1 2026 earnings on April 16, 2026, summarizing the period's financial results.
Rentokil Initial PLC Announces Annual Financial Report
Annual Report and Annual General Meeting CRAWLEY, UK / ACCESS Newswire / March 25, 2026 / In compliance with UK Listing Rule 6.4.1, the Company announces that the following documents, in unedited full...
Rentokil Initial price target raised to 575 GBp from 550 GBp at Citi
Citi analyst Marc Van’T Sant raised the firm’s price target on Rentokil Initial (RTO) to 575 GBp from 550 GBp and keeps a Buy rating on the shares. Published first…
Rentokil Initial upgraded to Buy from Neutral at UBS
UBS analyst Nicole Manion upgraded Rentokil Initial (RTO) to Buy from Neutral with a price target of 540 GBp, up from 430 GBp. The firm says that for the first…
Rentokil Initial upgraded to Neutral from Sell at Rothschild & Co Redburn
Rothschild & Co Redburn upgraded Rentokil Initial (RTO) to Neutral from Sell with a 470 GBp price target
Rentokil Initial price target raised to 550 GBp from 520 GBp at Morgan Stanley
Morgan Stanley raised the firm’s price target on Rentokil Initial (RTO) to 550 GBp from 520 GBp and keeps an Overweight rating on the shares.
Rentokil Initial price target raised to $35 from $30 at Oppenheimer
Oppenheimer raised the firm’s price target on Rentokil Initial (RTO) to $35 from $30 and keeps an Outperform rating on the shares. The firm notes Rentokil’s Q4 revenues of $1.7B…
Rentokil Initial price target raised to 550 GBp from 500 GBp at Citi
Citi analyst Marc Van’T Sant raised the firm’s price target on Rentokil Initial (RTO) to 550 GBp from 500 GBp and keeps a Buy rating on the shares. Published first…
Rentokil Initial price target raised to 550 GBp from 520 GBp at Morgan Stanley
Morgan Stanley analyst Annelies Vermeulen raised the firm’s price target on Rentokil Initial (RTO) to 550 GBp from 520 GBp and keeps an Overweight rating on the shares. The firm,…
Rentokil Initial price target raised to 550 GBp from 520 GBp at Morgan Stanley
Morgan Stanley raised the firm’s price target on Rentokil Initial (RTO) to 550 GBp from 520 GBp and keeps an Overweight rating on the shares.